-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722.P1.59 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 5, 2015: 5:30 PM-7:30 PM
Hall A, Level 2 (Orange County Convention Center)

Ifigeneia Tzannou, MD1*, Bilal Omer, MD1, Anastasia Papadopoulou, PhD1*, Ulrike Gerdemann, MD1*, Colton Smith, PhD2*, Adrian P. Gee, PhD1, Bambi J Grilley1*, Malcolm K. Brenner, MB, PhD, FRCP, FRCPath1, Catherine M. Bollard, MD3,4, Ann M. Leen, PhD1, Cliona M. Rooney, PhD1* and Helen E. Heslop, MD1

1Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX
2Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
3Children's National Hospital, Washington, DC
4The George Washington University, Washington, DC

Sachiko Seo, MD, Ph.D.1, Jeffrey Yu2*, Isaac C Jenkins, MS3*, Terry L Stevens-Ayers, MS1*, Kuypers M Jane, PhD4*, Huang Meei-Li, PhD4*, Wendy M Leisenring, PhD5*, Keith R Jerome, MD, PHD4*, Sophie Paczesny, MD, PhD2 and Michael Boeckh, MD1

1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2Indiana University School of Medicine, Indianapolis, IN
3Clinical Statistics Division, Fred Hutchinson Cancer Research Center, Seattle, WA
4Department of Laboratory Medicine, University of Washington, Seattle, WA
5Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Yuriko Kishi1*, Yusuke Meguri, MD1*, Miki Iwamoto1*, Takeru Asano, MD1*, Takanori Yoshioka, MD1*, Yoshinobu Maeda, MD, PhD1*, Mitsune Tanimoto, MD, PhD1, John Koreth, MBBS, DPhil2, Jerome Ritz, MD2 and Ken-Ichi Matsuoka, MD, PhD1*

1Department of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
2Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA

Attilio Bondanza, MD, PhD1, Loredana Ruggeri2*, Dimitris Ziagkos3*, Chiara Bonini, MD4, Christian Chabannon5, Natalia Bootsman3*, Cora Knol-Bout3*, Liesbeth De Wreede3*, Maddalena Noviello, PhD6*, Lara Crucitti, MD7*, Luca Vago, MD, PhD8, Alessandra Carotti9*, Adelmo Terenzi9*, Mara Merluzzi9*, Maria Speranza Massei2*, Lucia Amico2*, Sara Piccinelli2*, Joan Hendrik Veelken10*, Yener Koc, MD11, Peter Bader, MD12, Bernd Gruhn, MD13*, Franco Locatelli, MD, PhD14, Fabio Ciceri, MD15*, Antoine Toubert16* and Andrea Velardi17

1Innovative Immunotherapies Unit, San Raffaele Hospital Scientific Institute, Milan, Italy
2University of Perugia, Perugia, Italy
3Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, Netherlands
4Experimental Hematology Unit, San Raffaele Hospital Scientific Institute, Milan, Italy
5Cell therapy facility, Institut Paoli Calmettes, Marseille, France
6Experimental Hematology Unit, San Raffaele Scientific Institute, Milano, Italy
7Unit of Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milano, Italy
8Unit of Immunogenetics, Leukemia Genomics and Immunobiology, San Raffaele Scientific Institute, Milano, Italy
9Ospedale Santa Maria della Misericordia, Perugia, Italy
10Leiden University Medical Center, Leiden, Netherlands
11Medical Park Hospitals, Antalya, Turkey
12Division for Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany
13University Hospital of Jena, Jena, Germany
14University of Pavia, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
15Hematology and Bone Marrow Transplantation Unit, San Raffaele Hospital Scientific Institute, Milan, Italy
16INSERM UMR 1160, Hopital Saint-Louis - APHP, Paris, France
17Department of Medicine, University of Perugia, Perugia, Italy

Yi-Bin Chen, MD1, Shuli Li2*, Sarah Konkel3*, Colleen Loiselle3*, Yvonne A. Efebera, MD, MPH4, Steven M. Devine, MD4, Areej El-Jawahri, MD5, Steven L. McAfee, MD3*, Robert J. Soiffer, MD6, Jerome Ritz, MD7, Corey S Cutler, MD, MPH8 and Miguel Perales, MD9

1Massachusetts General Hospital, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3Division of Hematology / Oncology, Massachusetts General Hospital, Boston, MA
4Comprehensive Cancer Center, The Ohio State University, Columbus, OH
5Massachusetts General Hospital/Harvard Medical School, Boston, MA
6Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
7Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA
8Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
9Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY

Franco Locatelli, Prof, MD, PhD1*, Pietro Merli, MD2*, Giuseppina Li Pira, PhD2*, Valentina Bertaina, PhD2*, Barbarella Lucarelli, MD2*, Letizia Pomponia Brescia, MD2*, Mauro Montanari, MD3*, Daniela Pende, MD4*, Michela Falco, PhD5*, Daria Pagliara, MD6*, Maria Giuseppina Cefalo, MD2*, Alessandro Moretta, MD7*, Concetta Quintarelli, PhD6*, Brigitte Strahm, MD8*, Waseem Qasim, MBBS PhD9*, Mary Slatter10*, Lorenzo Moretta, MD2*, Annemarie Moseley, MD, PhD11* and Alice Bertaina, MD, PhD6

1Oncoematologia Pediatrica, Ospedale Pediatrico Bambino Gesù, Rome, Italy
2Ospedale Pediatrico Bambino Gesù, Rome, Italy
3Department of Hematology, Ospedale Pediatrico Bambino Gesù, Rome, Italy
4Department of Immunology, IRCCS AUO San Martino-IST, Genova, Italy
5Giannina Gaslini Hospital, Genova, Italy
6Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
7University of Genoa, Genoa, Italy
8University Children´s Hospital Freiburg, Division of Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany
9Institute of Child Health / Molecular and Cellular Immunology Unit, University College London, London, United Kingdom
10Newcastle upon Tyne, Newcastle, United Kingdom
11Bellicum Pharmaceuticals, Houston, TX

Julie R. Boiko, MS1,2, Annie Im, MD3, Xiaohua Chen, MD PhD1*, Memphis J Hill, BS1* and Paul Szabolcs, MD1

1Department of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapies, Children's Hospital of Pittsburgh, Pittsburgh, PA
2University of Pittsburgh School of Medicine, Pittsburgh, PA
3Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA

Jin S. Im, MD, PhD1*, Rima M Saliba, Ph.D1*, Susan C Abraham, MD2*, William Ross, MD3*, Gabriela Rondon, MD1, Asif Rashid, MD2*, Elizabeth J. Shpall, MD1, Uday R. Popat, MD1, Muzaffar Qazilbash, M.D.1, Chitra M. Hosing, MD1, Betul Oran, MD1, Nina Shah, MD1, Richard E. Champlin, MD1 and Amin M. Alousi, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Gastroenterology Hepat & Nutr, The University of Texas MD Anderson Center Center, Houston, TX

Mayada Salman Abu Shanap, MD1*, Sarah Cooley, MD2, Xianghua Luo, Ph.D.1*, Cao Qing1*, Julie Curtsinger, Ph.D.1*, Rachel Bergerson, Ph.D.1*, Nelli Bejanyan1*, Heather Stefanski, MD, Ph.D.1*, Claudio Brunstein, MD1*, Daniel J. Weisdorf, MD2, Bruce R. Blazar, MD3, Jeffrey S. Miller, MD2, John E Wagner, MD1* and Michael R. Verneris, MD4

1University of Minnesota, Minneapolis, MN
2Adult and Pediatric Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN
3Division of Pediatrics, Department of Medicine, University of Minnesota Cancer Center, Minneapolis, MN
4Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN

Mark A. Schroeder, MD1, Jaebok Choi, PhD2, Matthew L Cooper, PhD2, David Schwab, BA CCRP2*, Sarah Willey2*, Jingxia (Esther) Liu, PhD.3*, Matthew Holt4*, Linda Eissenberg4*, Iskra Pusic, MD1, Armin Ghobadi, MD4*, Rizwan Romee, MD1, John S. Welch, MD, PhD5, Keith Stockerl-Goldstein, MD6, Camille N. Abboud, MD, FACP1, Ravi Vij, MD7, Geoffrey L. Uy, MD2, Peter Westervelt, MD, PhD5 and John F Dipersio, MD, PhD2

1BMT and Leukemia Program, Washington University School of Medicine, Saint Louis, MO
2Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
3Department of Biostatistics, Washington University in Saint Louis, Saint Louis, MO
4Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
5Division of Oncology, Washington University School of Medicine, St. Louis, MO
6Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO
7Washington University, St. Louis, MO

Edouard Forcade1,2*, Céline Cognet3*, Xavier Sicard3*, Sophie Daburon2*, Pascale Duchez2,3,4*, Zoran Ivanovic2,3,4*, Vincent Pitard2*, Julie Déchanet-Merville2*, Emmanuel Clave5*, Antoine Toubert5*, Stephane Vigouroux1*, Reza Tabrizi1, Mathieu Sauvezie1*, Arnaud Pigneux6,7*, Jean-Francois Moreau2,3*, Noel Milpied7,8 and Jean-Luc Taupin2,3*

1Service d’Hematologie Clinique et Therapie Cellulaire, CHU de Bordeaux, Pessac, France
2UMR CNRS 5164, Bordeaux University, Bordeaux, France
3Laboratoire d’Immunologie – Immunogénétique, CHU de Bordeaux, Bordeaux, France
4EFS Aquitaine - Limousin, Bordeaux, France
5INSERM UMR 1160, Hopital Saint-Louis - APHP, Paris, France
6Hematology, Hôpital Haut Lêveque, Pessac, France
7INSERM UMR 1035, Bordeaux University, Bordeaux, France
8Service d’Hematologie Clinique et Therapie Cellulaire, CHU Haut-Lévêque, Bordeaux, France

Annie Im, MD1,2, Frances T. Hakim, PhD3*, Filip Pirsl2*, Seth M. Steinberg, PhD4*, Lauren M. Curtis, MD2, Sandra A. Mitchell, CRNP, PhD, AOCN5*, Edward W. Cowen, MD, MHSc6*, Jennifer Hsu, RN2*, Judy Baruffaldi2*, Licia Masuch2*, Juan C. Gea-Banacloche, MD2*, David C. Halverson, MD3*, Daniel H. Fowler, MD2*, Ronald E. Gress, MD2 and Steven Z. Pavletic, MD2

1Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA
2Experimental Transplantation and Immunology Branch, National Institutes of Health, National Cancer Institute, Bethesda, MD
3Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
4Biostatistics and Data Management Section, National Cancer Institute, Bethesda, MD
5Outcomes Research Branch, Division of Cancer Control and Population Sciences, National Institutes of Health, National Cancer Institute, Bethesda, MD
6Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD

H. Jean Khoury1, Vamsi Kota, M.B;B.S2, Martha Arellano, MD1, Stephanie L Bauer, ANP3*, Anand P Jillella, MD1, Amelia Langston, MD1, Zaid Al-Kadhimi, MD4*, Zachariah DeFilipp, MD5, Audrey S Kim, RN2*, Elliott F. Winton, MD1 and John F Dipersio, MD, PhD6

1Winship Cancer Institute of Emory University, Atlanta, GA
2Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta
3Washington University Physicians, Washington University School of Medicine in St Louis, St. Louis
4Hematology, Winship Cancer Institute of Emory University, Atlanta, GA
5Department of Hematology and Medical Oncology, Winship Cancer Institute, Winship Cancer Institute of Emory University, Atlanta, GA
6Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO

Lotte van der Wagen, MD1*, Liane CJ te Boome, MD1,2, Inger Nijhof1*, Marieke Schoordijk3*, Denise Buter1*, Ellen Meijer, MD PhD4 and Jurgen Kuball, MD PhD1

1Hematology, University Medical Center Utrecht, Utrecht, Netherlands
2Hematology, MC Haaglanden, Den Haag, Netherlands
3Hematology, VU University Medical Center, Amsterdam, Netherlands
4Hematology, VU University Medical Center, Amsterdam, Netherlands

Takeshi Sugio, MD1*, Koji Kato, MD, PhD1, Takatoshi Aoki, MD2*, Takanori Ota, MD3*, Noriyuki Saito, MD4*, Shuro Yoshida, MD4*, Ichiro Kawano, MD4*, Hideho Henzan, MD4*, Ken Takase, MD5*, Tsuyoshi Muta, MD, PhD6*, Kohta Miyawaki, MD1*, Takahiro Shima, MD, PhD1*, Shuichiro Takashima, MD, PhD1*, Takuji Yamauchi, MD, PhD1*, Yasuo Mori, MD, PhD1*, Goichi Yoshimoto, MD, PhD1*, Kenjiro Kamezaki, MD, PhD1, Katsuto Takenaka, MD, PhD1, Tomohiko Kamimura, MD, PhD2*, Yuju Ohno, MD, PhD3*, Tetsuya Eto, MD, Ph.D4*, Ryosuke Ogawa, MD, PhD6, Hiromi Iwasaki, MD, PhD7, Toshihiro Miyamoto, MD, PhD1 and Koichi Akashi, MD, PhD1,7

1Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
2Department of Hematology, Harasanshin Hospital, Fukuoka, Japan
3Department of Internal Medicine, Kitakyushu Municipal Medical Center, Fukuoka, Japan
4Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan
5Department of Hematology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
6Department of Hematology / Oncology, Japan Community Healthcare Organization Kyushu Hospital, Kita-Kyushu, Japan
7Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan

Sung-Eun Lee1*, Ji-Young Lim1*, Da-Bin Ryu1*, Tae Woo Kim1*, Young-Woo Jeon1*, Jae-Ho Yoon, M.D.1*, Byung-Sik Cho, M.D.2*, Ki-Seong Eom1*, Yoo-Jin Kim1*, Hee-Je Kim1*, Seok Lee1*, Seok-Goo Cho1*, Dong-Wook Kim1*, Jong Wook Lee1, Woo-Sung Min, M.D.3* and Chang-Ki Min1*

1Department of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea
2Hematology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
3Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, Seoul St. Mary’s hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea

Ronit Yerushalmi, MD1, Noga Shem-Tov, MD1*, Ivetta Danylesko, MD1*, Arnon Nagler, MD, MSc1 and Avichai Shimoni, MD2*

1Hematology Division and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Tel-Aviv, Israel
2Hematology Division, Chaim Sheba Medical Center and Tel Aviv University, Tel-Hashomer, Ramat-Gan, Israel

Jing Bo Wang, PhD1*, Xin Hong Fei1*, Hao Yu Cheng2*, Yu Ming Yin2*, Wei Jie Zhang2*, Shu Qin Zhang2*, Qian Li2*, Song Xue2*, Jiang Ying Gu2*, Jun Bao He2*, Fan Yang2*, Meng Qi Liu2*, Jie Zhao2* and Dai-Hong Liu3

1Department of hematology, Aerospace Center Hospital Of Peking University, BeiJing, China
2Department of hematology, Aerospace Center Hospital Of Peking University, Beijing, China
3Department of Hematology, Chinese PLA General Hospital, Beijing, China

Rohini Radia, MBChB1*, Emma Das-Gupta, MD2*, Guillermo Orti, M.D.3*, Donal McLornan, MD PhD4,5*, Majid A. Kazmi6,7, Christopher P Fox, PhD8*, Jenny L. Byrne, PhD9*, Nigel H. Russell, MD10 and Kavita Raj, MD, PhD11,12

1Centre for Haematology, University Hospital Nottingham NHS Foundation Trust, Nottingham, United Kingdom
2Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
3King's College Hospital NHS Trust Foundation Trust, London, United Kingdom
4Department of Haematological Medicine, King’s College Hospital NHS Foundation Trust, London, United Kingdom
5Guy's and St Thomas' Hospital NHS Trust, London, United Kingdom
6King's College Hospitals NHS Foundation Trust, London, United Kingdom
7Haematology, Guy's & St. Thomas' NHS Trust, London, United Kingdom
8Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
9Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham, United Kingdom
10Centre for Clinical Haematology, Nottingham University Hospital, Nottingham, United Kingdom
11Department of Haematolgical Medicine,, King's College Hospital, NHS Foundation Trust,, London, United Kingdom
12Guy's and St. Thomas' NHS Trust, London, United Kingdom

Marc Poch Martell, MD1*, Elizabeth Shin2*, Jieun Uhm, MD1, Fotios V. Michelis, MD, PhD1, Auro Viswabandya, MD, DM1, Jeffrey H. Lipton, MD, PhD1, Hans A. Messner, M.D./Ph.D1 and Dennis Dong Hwan Kim, MD/PhD1

1Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
2University of Toronto, Toronto, ON, Canada

Lining Wang1,2,3*, Emmanuel Raffoux, MD, PhD1*, Xavier Thomas4, Ibrahim Yakoub-Agha, MD, PhD5, Jean Henri Bouhris6*, Stephane de Botton7*, Mauricette Michallet, MD, PhD8, Stephanie Nguyen quoc, MD9*, Sylvain P Chantepie, MD10,11*, Eric Deconinck12, Denis Caillot13*, Pascal Turlure, MD14*, Stephane Vigouroux15*, Arnaud Pigneux16*, Anne Huynh, MD17*, Jean Valère Malfuson, MD18*, Michael Loschi, MD19*, Gerard Socie20, Herve Dombret, MD21, Regis Peffault de la Tour, MD, PhD22* and Thomas Cluzeau, MD, PhD23,24*

1Hematology Department, Saint Louis Hospital, Paris, France
2Stem Cell Transplantation Department, Saint Louis Hospital, Paris, France
3Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Hematology, Shangai, China
4Hematology, Centre Hospitalier Lyon-Sud, Pierre Bénite, France
5Hematology, CHU de Lille, Lille, France
6Stem Cell Transplantation, Institut Gustave Roussy, Villejuif, France
7Institut Gustave Roussy, Villejuif, France
8Department of Hematology, Centre Hospitalier Lyon-Sud, Lyon, France
9Department of Hematology, Pitié-Salpétrière Hospital, Paris, France
10Haematology Department, Caen University Hospital, Caen, France
11ALFA group, ^Paris, France
12Hematology, INSERM UMR1098 - CHU Jean Minjoz, Besancon, France
13Hôpital du Bocage, Dijon, France
14Hematology Department, CHU Limoges, Limoges, France
15Service d’Hematologie Clinique et Therapie Cellulaire, CHU de Bordeaux, Pessac, France
16Hematology, Hôpital Haut Lêveque, Pessac, France
17institut universitaire du cancer, Oncopole, TOULOUSE, France
18Hematology Department, Percy Hospital, Clamart, France
19Hospital, Rouen, France
20St-Louis Hospital, Paris, France
21Hopital Saint Louis, Paris, France
22Department of Hematology, Saint Louis Hospital, Paris, France
23INSERM U1065, Centre Mediterraneen de Medecine Moleculaire, Nice, France
24Hematology, Saint Louis Hospital, Paris, France

Yannick Le Bris, PharmD1*, Thierry Guillaume, MD, PhD2*, Marina Iliaquer, PharmD3*, Jerome Martin, PharmD, PhD4*, Pierre Peterlin, MD2*, Audrey Menard1*, Marion Eveillard, PharmD1*, Soraya Wuilleme, PharmD, PhD1*, Nelly Robillard, PhD1*, Jacques Delaunay, MD2*, Mohamad Mohty, MD, PhD5, Alice Garnier, MD2*, Philippe Moreau, MD, PhD2*, Marie C Bene, PharmSciD, PhD1* and Patrice Chevallier, MD, PhD2*

1Hematology Laboratory, Nantes University Hospital, Nantes, France
2Department of Hematology, Nantes University Hospital, Nantes, France
3Virology, CHU, Nantes, France
4Immunology, CHU, Nantes, France
5Hematology, Hospital Saint-Antoine, Paris University UPMC, INSERM U938, Paris, France

Sita D. Bhella, MD1, Elizabeth Shin2*, Marc Poch Martell, MD3*, Jieun Uhm, MD4, Fotios V. Michelis, MD, PhD3, Auro Viswabandya, MD, DM3, Jeffrey H. Lipton, MD, PhD5, Hans A. Messner, PhD6 and Dennis Dong Hwan Kim, MD, PhD7

1Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
2University of Toronto, Toronto, ON, Canada
3Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
4Department of Hematology & Oncology, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, South Korea
5Med. Onc. & Hem., Princess Margaret Hospital, Toronto, ON, Canada
6Princess Margaret Hospital, Toronto, ON, Canada
7Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

Huiying Qiu, MD1*, Brenda M. Sandmaier, MD1,2, Barry E. Storer, PhD2,3*, Thomas Chauncey, MD, PhD2,4*, Finn Petersen, MD5, Michael A. Pulsipher6,7, Benedetto Bruno, MD8*, Mary Flowers, MD1,2, Marco Mielcarek, MD1,2*, Rainer Storb, MD1,2 and David G Maloney, MD, PhD3,9

1Fred Hutchinson Cancer Research Center, Seattle, WA
2University of Washington, Seattle, WA
3Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
4VA Puget Sound Health Care System, Seattle, WA
5LDS Hospital, Salt Lake City, UT
6University of Utah, Salt Lake City, UT
7Children's Hospital of Los Angeles, Los Angeles, CA
8Torino University, Torino, Italy
9Division of Medical Oncology, University of Washington, Seattle, WA

Brian T Hess, MD1, Feng Gao, PhD2*, John F. DiPersio, MD, PhD3, Peter Westervelt, MD, PhD4, Ravi Vij, MD5, Geoffrey L. Uy, MD6, Keith Stockerl-Goldstein, MD7, Camille N. Abboud, MD, FACP1, Mark A. Schroeder, MD1, Iskra Pusic, MD1, Armin Ghobadi, MD3*, Amanda F. Cashen, MD4, Todd A Fehniger, MD, PhD1, Meagan A. Jacoby, MD, PhD8 and Rizwan Romee, MD1

1BMT and Leukemia Program, Washington University School of Medicine, Saint Louis, MO
2Department of Biostatistics, Washington University School of Medicine, Saint Louis, MO
3Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
4Division of Oncology, Washington University School of Medicine, St. Louis, MO
5Washington University, St. Louis, MO
6Division of Oncology, Washington University School of Medicine, Saint Louis, MO
7Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO
8Department of Medicine, Division of Oncology, Washington University in St. Louis, Saint Louis, MO

Xiaohua Chen, MD PhD1*, Mark Vander Lugt, MD2*, Memphis J Hill, BS1* and Paul Szabolcs, MD1

1Department of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapies, Children's Hospital of Pittsburgh, Pittsburgh, PA
2Department of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapies, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA

Gunhan Gurman, MD1*, Pinar Ataca, MD2*, Erden Atilla, MD2*, Sinem Civriz Bozdag, MD2*, Selami Kocak Toprak, MD2*, Meltem Kurt Yuksel, MD2*, Taner Demirer, MD2*, Hamdi Akan, MD2*, Onder Arslan, MD2*, Pervin Topcuoglu, MD1*, Meral Beksac, MD2, Osman Ilhan2* and Muhit Ozcan, MD3

1Ankara University Faculty of Medicine Department of Hematology, Ankara, Turkey
2Ankara University School of Medicine Department of Hematology, Ankara, Turkey
3Ankara University School of Medicine, Ankara, Turkey

Patrizia Chiusolo1*, Elisabetta Metafuni2*, Francesco Paroni Sterbini3*, Sabrina Giammarco2*, Luca Masucci3*, Giuseppe Leone, MD4 and Simona Sica1*

1Institute of Hematology, Catholic University, Rome, Italy
2Hematology Department, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy
3Microbiology Department, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy
4Hematology, Catholic University, Rome, Italy

Mary Christa Krupski, DO, MPH1, Andrew Bodiford, PharmD1*, Kathryn Culos, PharmD, BCOP1*, Adetola A. Kassim, MD, MS2, Brian G. Engelhardt, MD2, John P. Greer, MD3, Bipin N. Savani, MD4, Wichai Chinratanalab, MD4 and Madan Jagasia, MBBS, MS5

1Vanderbilt University, Nashville, TN
2Hematology and Stem Cell Transplantation Section, Division of Hematology/ Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
3Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
4Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN
5Hematology/Stem Cell Transplant, Vanderbilt University Medical Center, Nashville, TN

Christelle Retiere, PhD1*, Catherine Willem1*, Thierry Guillaume, MD, PhD2*, Henri Vié, PhD3*, Laetitia Gautrot-Rolland1*, Emmanuel Scotet3*, Xavier Saulquin3*, Katia Gagne, PhD1*, Beatrice Clemenceau, PhD3*, Pierre Peterlin, MD2*, Alice Garnier, MD2*, Marie-Christine Bene, MD4* and Patrice Chevallier, MD, PhD2*

1EA4271, EFS de Nantes, Nantes, France, Nantes, France
2Department of Hematology, Nantes University Hospital, Nantes, France
3INSERM U892, Nantes, France., Nantes, France
4Hopital Hotel Dieu, Laboratoire d'Hematologie, Nantes, France

*signifies non-member of ASH